サルコシン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "サルコシン" in Japanese language version.

refsWebsite
Global rank Japanese rank
2nd place
6th place
4th place
24th place

doi.org

  • “Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism”. Metabolism 42 (11): 1448–60. (November 1993). doi:10.1016/0026-0495(93)90198-W. PMID 7694037. 
  • “Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression”. Biological psychiatry 74 (10). (2013). doi:10.1016/j.biopsych.2013.02.020. PMID 23562005. 
  • “Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia”. Biological Psychiatry 60 (6): 645–9. (September 2006). doi:10.1016/j.biopsych.2006.04.005. PMID 16780811. 
  • “Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia”. Biological Psychiatry 55 (5): 452–6. (March 2004). doi:10.1016/j.biopsych.2003.09.012. PMID 15023571. 
  • “Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study”. Biological psychiatry 63 (1). (2008). doi:10.1016/j.biopsych.2007.04.038. PMID 17659263. 

nih.gov

pubmed.ncbi.nlm.nih.gov

  • “Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism”. Metabolism 42 (11): 1448–60. (November 1993). doi:10.1016/0026-0495(93)90198-W. PMID 7694037. 
  • “Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression”. Biological psychiatry 74 (10). (2013). doi:10.1016/j.biopsych.2013.02.020. PMID 23562005. 
  • “Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia”. Biological Psychiatry 60 (6): 645–9. (September 2006). doi:10.1016/j.biopsych.2006.04.005. PMID 16780811. 
  • “Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia”. Biological Psychiatry 55 (5): 452–6. (March 2004). doi:10.1016/j.biopsych.2003.09.012. PMID 15023571. 
  • “Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study”. Biological psychiatry 63 (1). (2008). doi:10.1016/j.biopsych.2007.04.038. PMID 17659263.